As of January 22, 2025, MacroGenics (MGNX) has a market cap of $0.20 billion USD. According to our data, MacroGenics is ranked No.7132 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.20 B |
-4.31%
|
Dec 31, 2024 | $0.20 B |
-66.22%
|
Dec 29, 2023 | $0.60 B |
43.37%
|
Dec 30, 2022 | $0.42 B |
-58.19%
|
Dec 31, 2021 | $1.01 B |
-29.79%
|
Dec 31, 2020 | $1.43 B |
110.11%
|
Dec 31, 2019 | $0.68 B |
-14.33%
|
Dec 31, 2018 | $0.80 B |
-33.16%
|
Dec 29, 2017 | $1.19 B |
-7.05%
|
Dec 30, 2016 | $1.28 B |
-34.00%
|
Dec 31, 2015 | $1.94 B |
-11.69%
|
Dec 31, 2014 | $2.20 B |
27.85%
|
Dec 31, 2013 | $1.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$365.09 B |
95.523 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Novo Nordisk
NVO
|
$335.32 B |
64.114 B
|
Denmark
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CSL
CSL.AX
|
$82.06 B |
-0.963 B
|
Australia
|
Zoetis
ZTS
|
$75.17 B |
-0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.96 B |
0.455 B
|
Japan
|
Market Cap | = | MGNX Stock Price | * | MGNX Shares Outstanding |
= | $3.11 | * | 62.76 M | |
= | $0.20 B |